Henry, Linda <br/><br/>
Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.  [electronic resource] 

 -  Expert review of pharmacoeconomics & outcomes research  Dec 2016 
 - 659-665 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8379 
<br/><br/><label>Standard No.: </label>10.1080/14737167.2016.1244007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Cost-Benefit Analysis<br/>Fluorenes--administration & dosage<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Medication Adherence<br/>Sofosbuvir--administration & dosage<br/>Treatment Outcome<br/>United States